95 related articles for article (PubMed ID: 38487531)
21. Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
Saad MB; Hong L; Aminu M; Vokes NI; Chen P; Salehjahromi M; Qin K; Sujit SJ; Lu X; Young E; Al-Tashi Q; Qureshi R; Wu CC; Carter BW; Lin SH; Lee PP; Gandhi S; Chang JY; Li R; Gensheimer MF; Wakelee HA; Neal JW; Lee HS; Cheng C; Velcheti V; Lou Y; Petranovic M; Rinsurongkawong W; Le X; Rinsurongkawong V; Spelman A; Elamin YY; Negrao MV; Skoulidis F; Gay CM; Cascone T; Antonoff MB; Sepesi B; Lewis J; Wistuba II; Hazle JD; Chung C; Jaffray D; Gibbons DL; Vaporciyan A; Lee JJ; Heymach JV; Zhang J; Wu J
Lancet Digit Health; 2023 Jul; 5(7):e404-e420. PubMed ID: 37268451
[TBL] [Abstract][Full Text] [Related]
22. Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.
Himuro H; Nakahara Y; Igarashi Y; Kouro T; Higashijima N; Matsuo N; Murakami S; Wei F; Horaguchi S; Tsuji K; Mano Y; Saito H; Azuma K; Sasada T
Cancer Immunol Immunother; 2023 Aug; 72(8):2829-2840. PubMed ID: 37188764
[TBL] [Abstract][Full Text] [Related]
23. g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update).
Kolberg L; Raudvere U; Kuzmin I; Adler P; Vilo J; Peterson H
Nucleic Acids Res; 2023 Jul; 51(W1):W207-W212. PubMed ID: 37144459
[TBL] [Abstract][Full Text] [Related]
24. Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
Scirocchi F; Strigari L; Di Filippo A; Napoletano C; Pace A; Rahimi H; Botticelli A; Rughetti A; Nuti M; Zizzari IG
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430974
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
Széles Á; Fazekas T; Váncsa S; Váradi M; Kovács PT; Krafft U; Grünwald V; Hadaschik B; Csizmarik A; Hegyi P; Váradi A; Nyirády P; Szarvas T
Cancer Immunol Immunother; 2023 May; 72(5):1061-1073. PubMed ID: 36385210
[TBL] [Abstract][Full Text] [Related]
26. Stratifin as a novel diagnostic biomarker in serum for diffuse alveolar damage.
Arakawa N; Ushiki A; Abe M; Matsuyama S; Saito Y; Kashiwada T; Horimasu Y; Gemma A; Tatsumi K; Hattori N; Tsushima K; Miyashita K; Saito K; Nakamura R; Toyoda T; Ogawa K; Sato M; Takamatsu K; Mori K; Nishiya T; Izumi T; Ohno Y; Saito Y; Hanaoka M
Nat Commun; 2022 Oct; 13(1):5854. PubMed ID: 36195613
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade.
Harel M; Lahav C; Jacob E; Dahan N; Sela I; Elon Y; Raveh Shoval S; Yahalom G; Kamer I; Zer A; Sharon O; Carbone DP; Dicker AP; Bar J; Shaked Y
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35718373
[TBL] [Abstract][Full Text] [Related]
28. Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer.
Niu M; Liu Y; Yi M; Jiao D; Wu K
Front Immunol; 2022; 13():827921. PubMed ID: 35386715
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous Genetic Ablation of PD-1, LAG-3, and TIM-3 in CD8 T Cells Delays Tumor Growth and Improves Survival Outcome.
Ciraolo E; Althoff S; Ruß J; Rosnev S; Butze M; Pühl M; Frentsch M; Bullinger L; Na IK
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328630
[TBL] [Abstract][Full Text] [Related]
30. Intrapulmonic Cavity or Necrosis on Baseline CT Scan Serves as an Efficacy Predictor of Anti-PD-(L)1 Inhibitor in Advanced Lung Squamous Cell Carcinoma.
Lu T; Zhang L; Chen M; Zheng X; Jiang K; Zheng X; Li C; Xiao W; Miao Q; Yang S; Lin G
Cancer Manag Res; 2021; 13():5931-5939. PubMed ID: 34354375
[TBL] [Abstract][Full Text] [Related]
31. TMB in NSCLC: A Broken Dream?
Bravaccini S; Bronte G; Ulivi P
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207126
[TBL] [Abstract][Full Text] [Related]
32. New Insights into the Clinical Implications of Yes-Associated Protein in Lung Cancer: Roles in Drug Resistance, Tumor Immunity, Autophagy, and Organoid Development.
Yoo G; Park D; Kim Y; Chung C
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34202980
[TBL] [Abstract][Full Text] [Related]
33. B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy.
Zhao Y; Cao Y; Chen Y; Wu L; Hang H; Jiang C; Zhou X
Immunology; 2021 Nov; 164(3):507-523. PubMed ID: 34115389
[TBL] [Abstract][Full Text] [Related]
34. Immunotherapy for Advanced Non-Small Cell Lung Cancer: A Decade of Progress.
Shields MD; Marin-Acevedo JA; Pellini B
Am Soc Clin Oncol Educ Book; 2021 Mar; 41():1-23. PubMed ID: 33979196
[TBL] [Abstract][Full Text] [Related]
35. Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review.
Indini A; Rijavec E; Grossi F
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918661
[TBL] [Abstract][Full Text] [Related]
36. Host response to immune checkpoint inhibitors contributes to tumor aggressiveness.
Khononov I; Jacob E; Fremder E; Dahan N; Harel M; Raviv Z; Krastev B; Shaked Y
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33707313
[TBL] [Abstract][Full Text] [Related]
37. T lymphocytes related biomarkers for predicting immunotherapy efficacy in non-small cell lung cancer.
Wei X; Gu L; Heng W
Oncol Lett; 2021 Feb; 21(2):89. PubMed ID: 33376522
[TBL] [Abstract][Full Text] [Related]
38. Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy.
Khan M; Zhao Z; Arooj S; Fu Y; Liao G
Front Immunol; 2020; 11():587460. PubMed ID: 33329567
[TBL] [Abstract][Full Text] [Related]
39. VolcaNoseR is a web app for creating, exploring, labeling and sharing volcano plots.
Goedhart J; Luijsterburg MS
Sci Rep; 2020 Nov; 10(1):20560. PubMed ID: 33239692
[TBL] [Abstract][Full Text] [Related]
40. Lingering effects of chemotherapy on mature T cells impair proliferation.
Das RK; O'Connor RS; Grupp SA; Barrett DM
Blood Adv; 2020 Oct; 4(19):4653-4664. PubMed ID: 33002133
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
